Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement

J Thorac Cardiovasc Surg. 1986 Jun;91(6):874-8.

Abstract

Myocardial glycogen content was increased from a mean of 25.8 +/- 3.7 to 40.3 +/- 4.2 mumol/gm (p less than 0.0001) by an infusion of glucose, insulin, and potassium before mitral valve replacement. Patients who had received such an infusion and who had a higher myocardial glycogen content had a lower incidence of postoperative hypotension, less serious postoperative arrhythmias, and fewer serious complications after elective mitral valve replacement.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Glucose / administration & dosage*
  • Glycogen / analysis*
  • Heart Valve Prosthesis*
  • Humans
  • Insulin / administration & dosage*
  • Male
  • Middle Aged
  • Mitral Valve / surgery*
  • Myocardium / analysis*
  • Postoperative Complications / etiology*
  • Potassium / administration & dosage*
  • Preoperative Care*
  • Prospective Studies
  • Risk

Substances

  • Insulin
  • glucose-insulin-potassium cardioplegic solution
  • Glycogen
  • Glucose
  • Potassium